Smith+Nephew plc struck a deal to acquire Cartiheal Ltd. for $180 million at closing and $150 million in contingent payments, seven months after Bioventus Inc. backed out of its agreement to buy the developer of the Agili-C cartilage regeneration platform for $450 million. Read More
Asep Medical Holdings Inc. is expanding operations into China with a joint venture (JV) with Chinese medical diagnostics firm Sansure Biotech Inc., ramping up the race to commercialize sepsis diagnostics in Asia. Read More
Along with Enhertu, Astrazeneca plc now has another breast cancer treatment in its portfolio and it may also become a blockbuster. Truqap (capivasertib), combined with the company’s Faslodex (fulvestrant), is now U.S. FDA-approved for treating hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer. Read More
Apollo Neuroscience Inc. recently introduced a new software called Smartvibes for its Apollo wearable device to help people lower their stress levels and sleep better. There are a growing number of wearable technologies that have sensors that continuously measure physiological signals to help individuals monitor and manage their health conditions. Read More
Xenter Inc. is seeking patent protection for capacitive micromachined ultrasonic transducer (CMUT) containing medical devices, including intraluminal devices such as guidewires and catheters comprising sensors for imaging and/or measuring of one or more physiological parameters. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accelerate Diagnostics, Bracco, Bruker, Blackford, Broncus, CMI, Inspiremd, Iridex, Jiangliang, Life Molecular, Lyniate, Median Technologies, Orbusneich, RTI Surgical, Siemens Healthineers, Strattasys, Ulrich. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4D Medical, Awak, Brainspec. Read More
